Hologic, Inc.

NasdaqGS:HOLX Stock Report

Market Cap: US$16.6b

Hologic Management

Management criteria checks 4/4

Hologic's CEO is Steve MacMillan, appointed in Dec 2013, has a tenure of 12.08 years. total yearly compensation is $15.82M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 0.57% of the company’s shares, worth $95.45M. The average tenure of the management team and the board of directors is 2.3 years and 7.2 years respectively.

Key information

Steve MacMillan

Chief executive officer

US$15.8m

Total compensation

CEO salary percentage7.67%
CEO tenure12.1yrs
CEO ownership0.6%
Management average tenure2.3yrs
Board average tenure7.2yrs

Recent management updates

Recent updates

Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down

Sep 13
Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down

Analysts Have Made A Financial Statement On Hologic, Inc.'s (NASDAQ:HOLX) Third-Quarter Report

Aug 04
Analysts Have Made A Financial Statement On Hologic, Inc.'s (NASDAQ:HOLX) Third-Quarter Report

Is Hologic, Inc. (NASDAQ:HOLX) Trading At A 38% Discount?

Jul 19
Is Hologic, Inc. (NASDAQ:HOLX) Trading At A 38% Discount?

The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)

Jul 01
The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)

Is Hologic (NASDAQ:HOLX) Using Too Much Debt?

Jun 13
Is Hologic (NASDAQ:HOLX) Using Too Much Debt?

Hologic: Soft Performance, But Cheap Enough

May 06

Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward

Apr 18
Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward

Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Mar 11
Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Hologic, Inc. (NASDAQ:HOLX) Just Reported, And Analysts Assigned A US$80.53 Price Target

Feb 07
Hologic, Inc. (NASDAQ:HOLX) Just Reported, And Analysts Assigned A US$80.53 Price Target

Is Hologic (NASDAQ:HOLX) A Risky Investment?

Jan 31
Is Hologic (NASDAQ:HOLX) A Risky Investment?

Hologic: Reasonably, But Not Compellingly Valued

Jan 17

Here's What To Make Of Hologic's (NASDAQ:HOLX) Decelerating Rates Of Return

Jan 13
Here's What To Make Of Hologic's (NASDAQ:HOLX) Decelerating Rates Of Return

Hologic: Continued Room Amidst Bolt-On M&A Efforts

Oct 28

Hologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among Them

Aug 27

Hologic: Women's Health Play Looks Healthier Itself

May 13

CEO Compensation Analysis

How has Steve MacMillan's remuneration changed compared to Hologic's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 27 2025n/an/a

US$566m

Jun 28 2025n/an/a

US$557m

Mar 29 2025n/an/a

US$557m

Dec 28 2024n/an/a

US$744m

Sep 28 2024US$16mUS$1m

US$790m

Jun 29 2024n/an/a

US$702m

Mar 30 2024n/an/a

US$467m

Dec 30 2023n/an/a

US$515m

Sep 30 2023US$16mUS$1m

US$456m

Jul 01 2023n/an/a

US$484m

Apr 01 2023n/an/a

US$753m

Dec 31 2022n/an/a

US$990m

Sep 24 2022US$14mUS$1m

US$1b

Jun 25 2022n/an/a

US$2b

Mar 26 2022n/an/a

US$2b

Dec 25 2021n/an/a

US$2b

Sep 25 2021US$15mUS$1m

US$2b

Jun 26 2021n/an/a

US$2b

Mar 27 2021n/an/a

US$2b

Dec 26 2020n/an/a

US$1b

Sep 26 2020US$14mUS$1m

US$1b

Jun 27 2020n/an/a

US$497m

Mar 28 2020n/an/a

US$453m

Dec 28 2019n/an/a

US$84m

Sep 28 2019US$12mUS$1m

-US$204m

Compensation vs Market: Steve's total compensation ($USD15.82M) is about average for companies of similar size in the US market ($USD13.49M).

Compensation vs Earnings: Steve's compensation has been consistent with company performance over the past year.


CEO

Steve MacMillan (61 yo)

12.1yrs
Tenure
US$15,819,261
Compensation

Mr. Stephen P. MacMillan, also known as Steve, serves as a Director of EZ LIFT Rescue Systems, Inc. and Business Leaders for Michigan. He served as an Independent Chairman of the Board at Illumina, Inc. fr...


Leadership Team

NamePositionTenureCompensationOwnership
Stephen MacMillan
Chairman12.1yrsUS$15.82m0.57%
$ 95.4m
Karleen Oberton
Chief Financial Officer7.4yrsUS$4.09m0.025%
$ 4.2m
Essex Mitchell
Chief Operating Officer2yrsUS$4.08m0.0091%
$ 1.5m
Jan Verstreken
Group President of Internationalno dataUS$3.59m0.050%
$ 8.2m
Paul Malenchini
Chief Information Officer4.5yrsno datano data
Michael Watts
Corporate Vice President of Investor Relations1.1yrsno datano data
Anne Liddy
General Counselless than a yearno data0.013%
$ 2.1m
Diana De Walt
Senior Vice President of Global Human Resources1.4yrsno datano data
Monica Berthelot
VP & Chief of Staff12yrsno datano data
Jennifer Schneiders
President of Diagnostic Solutions2.8yrsno data0.019%
$ 3.1m
Scott Christensen
Senior Vice President of Global Supply Chain & Regulatory Affairs2.3yrsno datano data
Brandon Schnittker
President of GYN Surgical Solutions2yrsno data0.0079%
$ 1.3m
2.3yrs
Average Tenure
57yo
Average Age

Experienced Management: HOLX's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Stephen MacMillan
Chairman12.1yrsUS$15.82m0.57%
$ 95.4m
Martin Madaus
Independent Director1.1yrsno data0.0026%
$ 431.7k
Stacey Stewart
Independent Director3yrsUS$329.95k0.00078%
$ 129.5k
Ludwig Hantson
Independent Director7.2yrsUS$329.95k0.0033%
$ 551.3k
Charles Dockendorff
Independent Director8.7yrsUS$354.95k0.0076%
$ 1.3m
Wayde McMillan
Independent Directorless than a yearno datano data
Christiana Stamoulis
Independent Director14.2yrsUS$329.95k0.020%
$ 3.4m
Amy Wendell
Lead Independent Director9.1yrsUS$357.45k0.0093%
$ 1.5m
Nanaz Mohtashami
Independent Director2.3yrsUS$329.95k0.0010%
$ 172.7k
7.2yrs
Average Tenure
61yo
Average Age

Experienced Board: HOLX's board of directors are considered experienced (7.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/02 17:18
End of Day Share Price 2025/12/31 00:00
Earnings2025/09/27
Annual Earnings2025/09/27

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hologic, Inc. is covered by 41 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Charles ButlerBarclays
Charley JonesBarrington Research Associates, Inc.